Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo Geerts

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Journal of Parkinson'S Disease|November 7, 2013
Phenotypic screening of the Prestwick library for treatment of Parkinson's tremor symptoms using a humanized quantitative systems pharmacology platformAthan Spiros, Patrick Roberts, Hugo Geerts
Frontiers in Pharmacology|October 7, 2015
Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacologyHugo Geerts, Patrick Roberts, Athan Spiros
Alzheimer'S Research & Therapy|November 28, 2012
Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug actionPatrick D Roberts, Athan Spiros, Hugo Geerts
CPT: Pharmacometrics & Systems Pharmacology|May 30, 2020
Salvaging CNS Clinical Trials Halted Due to COVID-19Hugo Geerts, Piet H van der Graaf
CNS Drug Reviews|December 14, 2002
Nicotinic cholinergic modulation: galantamine as a prototypeDiana S Woodruff-Pak, Cynthia Lander, Hugo Geerts
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 18, 2017
Knowledge-driven computational modeling in Alzheimer's disease research: Current state and future trendsHugo Geerts, Martin Hofmann-Apitius, Thomas J Anastasio, et al.
Schizophrenia Research|February 4, 2018
A quantitative systems pharmacology study on optimal scenarios for switching to paliperidone palmitate once-monthlyHugo Geerts, Athan Spiros, Patrick Roberts, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 23, 2013
Quantitative systems pharmacology as an extension of PK/PD modeling in CNS research and developmentHugo Geerts, Athan Spiros, Patrick Roberts, et al.
Frontiers in Pharmacology|April 19, 2013
A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer's diseaseHugo Geerts, Patrick Roberts, Athan Spiros, et al.
Journal of Psychopharmacology (Oxford, England)|February 19, 2015
Understanding responder neurobiology in schizophrenia using a quantitative systems pharmacology model: application to iloperidoneHugo Geerts, Patrick Roberts, Athan Spiros, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Journal of Parkinson'S Disease|November 7, 2013
Phenotypic screening of the Prestwick library for treatment of Parkinson's tremor symptoms using a humanized quantitative systems pharmacology platformAthan Spiros, Patrick Roberts, Hugo Geerts
Frontiers in Pharmacology|October 7, 2015
Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacologyHugo Geerts, Patrick Roberts, Athan Spiros
Alzheimer'S Research & Therapy|November 28, 2012
Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug actionPatrick D Roberts, Athan Spiros, Hugo Geerts
CPT: Pharmacometrics & Systems Pharmacology|May 30, 2020
Salvaging CNS Clinical Trials Halted Due to COVID-19Hugo Geerts, Piet H van der Graaf
CNS Drug Reviews|December 14, 2002
Nicotinic cholinergic modulation: galantamine as a prototypeDiana S Woodruff-Pak, Cynthia Lander, Hugo Geerts
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 18, 2017
Knowledge-driven computational modeling in Alzheimer's disease research: Current state and future trendsHugo Geerts, Martin Hofmann-Apitius, Thomas J Anastasio, et al.
Schizophrenia Research|February 4, 2018
A quantitative systems pharmacology study on optimal scenarios for switching to paliperidone palmitate once-monthlyHugo Geerts, Athan Spiros, Patrick Roberts, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 23, 2013
Quantitative systems pharmacology as an extension of PK/PD modeling in CNS research and developmentHugo Geerts, Athan Spiros, Patrick Roberts, et al.
Frontiers in Pharmacology|April 19, 2013
A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer's diseaseHugo Geerts, Patrick Roberts, Athan Spiros, et al.
Journal of Psychopharmacology (Oxford, England)|February 19, 2015
Understanding responder neurobiology in schizophrenia using a quantitative systems pharmacology model: application to iloperidoneHugo Geerts, Patrick Roberts, Athan Spiros, et al.
Pageof 8